Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension (The OVATION Study)

X
Trial Profile

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension (The OVATION Study)

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Iloprost (Primary) ; Nitric oxide
  • Indications Pulmonary hypertension
  • Focus Therapeutic Use
  • Acronyms OVATION
  • Most Recent Events

    • 24 May 2023 Results (n=23) to compare degree of vasoreactivity with iloprost and iNO and assess how this impacted subsequent clinical course, presented at the 119th International Conference of the American Thoracic Society.
    • 06 Mar 2023 Primary endpoint has been met. (Change in invasively measured pulmonary artery pressures after challenge with NO and iloprost), as per Results presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation
    • 06 Mar 2023 Results presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top